Skip to main content
Molecular Therapy logoLink to Molecular Therapy
. 2021 Jan 19;29(2):886. doi: 10.1016/j.ymthe.2020.12.020

RBP EIF2S2 Promotes Tumorigenesis and Progression by Regulating MYC-Mediated Inhibition via FHIT-Related Enhancers

Jiwei Zhang, Shengli Li, Ling Zhang, Juan Xu, Mingxu Song, Tingting Shao, Zhaohui Huang, Yongsheng Li
PMCID: PMC7854289  PMID: 33341125

(Mol Ther. 28, 1105–1118; April 8, 2020)

In the originally published version of this article, Figure 2I has errors as a result of incorrect image files being used to compose the panel. The corrected Figure 2I now appears below. These corrections do not change the conclusions of the paper.

The authors regret this error.

Figure 2I.

Figure 2I

EIF2S2 Increases GI Cancer Cell Proliferation, Invasion, and Metastasis In Vitro and In Vivo (Corrected)

Figure 2I.

Figure 2I

EIF2S2 Increases GI Cancer Cell Proliferation, Invasion, and Metastasis In Vitro and In Vivo (Original)


Articles from Molecular Therapy are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES